2、、AST顯著低于對照組,PA顯著高于對照組,差異有統(tǒng)計學意義(P〈0.05)。結論異甘草酸鎂及復方甘草酸苷在慢性肝炎的治療方面均有較好的效果,但是異甘草酸鎂與復方甘草酸苷比較更有優(yōu)勢,值得在臨床推廣應[關鍵詞]肝炎;異甘草酸鎂;復方甘草酸苷;病毒性肝炎酒精性脂肪性肝炎[中圖分類號]R575.1[文獻標識碼]B[文章編號]1673-9701(2016)24-0104-03[Abstract]ObjectiveTocomparetheclinicaleffectinpatientswithchronichepatitistreatedwithisogl
3、ycyrrhizinatemagnesiumandcompoundglycyrrhizin.Methods103patientswithchronichepatitiswhowereselectedfromSeptember2014toDecember2015inourhospitalwereretrospectivelyanalyzed,allthepatientsweredividedintotwogroupsaccordingtothetreatmentmethods,thestudygroup(52cases)wasgivenisoglyc
4、yrrhizinatemagnesiumtreatment,andthecontrolgroup(51cases)wasgivencompoundglycyrrhizintreatment.Theclinicalefficacyandtheliverfunctionofthetwogroupswerecomparedbeforeandaftertreatment.ResultsThetotalefficiencyofthestudygroupwassignificantlyhigherthanthatofthecontrolgroup,thedif
5、ferencewasstatisticallysignificant(P<0.05);Aftertreatment,ALT,TBIL,ASToftwogroupsweresignificantlylowerthanthosebeforetreatment,PAwassignificantlyhigherthanthosebeforetreatment,thedifferenceswerestatisticallysignificant(P〈0.05);ALT,TBIL,ASTofthestudygroupaftertreatmentweresign
6、ificantlowerthanthatofthecontrolgroup,PAofthestudygroupaftertreatmentwassignificanthigherthanthatofthecontrolgroup,thedifferenceswerestatisticallysignificant(P<0.05).ConclusionEffectofisoglycyrrhizinateandmagnesiumcompoundglycyrrhizininthetreatmentofchronichepatitisisbetter,bu
7、tisoglycyrrhizinatemagnesiumcompoundglycyrrhizincomparativeadvantage,itcanbeappliedinclinicalpractice.[Keywords]Hepatitis;Isoglycyrrhizinatemagnesium;Compoundglycyrrhizin;Viralhepatitis;Alcoholicsteatohepatitis慢性肝炎是我國臨床常見病、多發(fā)病。引發(fā)慢性肝炎的原較多,包括病毒感染、長期飲酒、藥物等,患者多以腹脹、惡心、嘔吐、黃疽等為主要臨床表現(xiàn)
8、,慢性肝炎分為輕、中、重度,病情越嚴重的患者預后越差,慢性肝炎對患者的身體健康造成嚴重影響,降低患者的生活質(zhì)量[1]。近年